Newborns with heart complications can rely on their newly developed immune systems to regenerate cardiac tissues, but adults ...
In the Nature Communications study, inhibiting RSK1 helped reverse the progression of MPNs in mice, reducing fibrosis, or scar formation, in the bone marrow. Inhibiting RSK1 eliminated up to 96% ...
Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI) is needed. Data from 313 825 acute MI hospitalizations ...
Introduction: Interleukin-10 (IL-10) is a potent immunomodulatory cytokine widely explored as a therapeutic agent for diseases, including myocardial infarction (MI ... of the entire left ventricular ...
Indeed, these studies form the scientific background to innovative therapeutic approaches that rely on recruitment of these cells to the damaged tissue and improvement of local cardiac stem cell ...
On the basis of our observations, we reviewed the available literature concerning scar or fibrous tissue production as influenced by angiotensin-converting enzyme, angiotensin II (an important ...